Michael John Sumner - 30 Jun 2024 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
30 Jun 2024
Net transactions value
$0
Form type
4
Filing time
01 Jul 2024, 17:02:25 UTC
Previous filing
16 May 2024
Next filing
18 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +2,917 +55% 8,219 30 Jun 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -2,917 -50% $0.000000 2,916 30 Jun 2024 Common Stock 2,917 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units is as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.